Using a multidisciplinary approach in research, combined with the knowledge from the fields of biology, physics and medicine, the direct and indirect effects of ionizing radiation on normal and human cancer cells are examined. In addition to conventional gamma radiation, most of the research relates to the effects of highly ionizing radiation, such as protons and carbon ions used in cancer therapy, as well as helium and oxygen ions. Innovative in vitro studies of the effects of FLASH radiotherapy are also planned, which represent the use of extremely high dose rates (≥ 40 Gy / s) for irradiation of tumor tissue that simultaneously protects the surrounding healthy tissue.
In addition, radiosensitization of cells using gold nanoparticles (AuNP) will be investigated, as well as the combined effects of radiation and chemotherapeutic agents and new agents used in targeted molecular therapy (anti-EGFR therapy). The main goal of research is to examine the cellular response to damage caused by conventional and highly ionizing radiation, as well as the improvement of modern therapeutic protocols. DNA damage response (DDR) is monitored using biological parameters, such as cell cycle changes, expression of certain genes involved in the DDR cascade, and the occurrence of various forms of cell death (apoptosis, senescence, and autophagy). Formation of phosphorylated H2AX nuclei (γ-H2AX) at sites of DNA double-strand breaks, in addition to clonogenic survival, which is the "gold standard" in radiation biology, is used as a biomarker for rapid detection and monitoring of cellular radiosensitivity in preclinical studies and in clinics.
In addition, the group is a member of the recently established international collaboration in the field of biophysics initiated by GSI, as well as the collaboration under the auspices of CERN, which is based on comparison and interpretation of experimental results using the numerical simulation tool GEANT4 (GEometry ANd Tracking) GEANT4-DNA extension. All these activities aim to improve modern therapeutic protocols for the treatment of certain types of cancer.
Istituto Nazionale di Fisica Nucleare, Laboratori Nazioneli del Sud (INFN-LNS)
Centre National de la Recherche Scientifique – CNRS, Centre d'Etudes Nucléaires de Bordeaux-Gradignan – CENBG, CNRS/IN2P3/Université Bordeaux
European Organization for Nuclear Research - Conseil Européen pour la Recherche Nucléaire (CERN)